Dr Reddy's expects first lot of Russia's COVID-19 vaccine Sputnik V by May end

Dr Reddy’s expects first lot of Russia’s COVID-19 vaccine Sputnik V by May end
Once available, SputnikV will be the third vaccine to be used in India against coronavirus.
By PTI|   Posted by Minhaj Adnan  |   Updated: 27th April 2021 3:17 pm IST
Hyderabad: Dr Reddy’s Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccineSputnik V,on Tuesday said it expects the first lot of stock from Russian Direct Investment Fund by May end.
In September 2020, Dr Reddys and RDIF entered into a partnership to conduct clinical trials of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India.

Related Keywords

India , Hyderabad , Andhra Pradesh , Russia , Pune , Maharashtra , Russian , Bharat , Kirill Dmitriev , Gamaleya National Research Institute Of Epidemiology , Serum Institute Of India , Russian Direct Investment Fund , Gamaleya National Research Institute , Bharat Biotech , Serum Institute , Domestic Manufacturing , Coronavirus Vaccine , Ldr Reddy , Sputnik V , Vaccine , இந்தியா , ஹைதராபாத் , ஆந்திரா பிரதேஷ் , ரஷ்யா , புனே , மகாராஷ்டிரா , ரஷ்ய , பாரத் , சீரம் நிறுவனம் ஆஃப் இந்தியா , ரஷ்ய நேரடி முதலீடு நிதி , பாரத் பயோடெக் , சீரம் நிறுவனம் , உள்நாட்டு உற்பத்தி ,